Research has generated several hypotheses for explaining the underlying pathophysiology of schizophrenia. This video focuses on dysfunction in dopaminergic signaling as a basis for positive symptoms and dysfunction in glutamatergic signaling as a mechanism for negative and cognitive symptoms.
Related content
Professor Dr. Merete Nordentoft introduces her work with the population of children of parents with schizophrenia. She also highlights the model implemented in Denmark, called VIA family, and why it is important to focus on children of parents living with schizophrenia.
Professor Dr. Christoph Correll highlights the recent innovations in the pharmacological treatment of schizophrenia.
Dr. Marco Solmi introduces what the mortality gap is and why there is a mortality gap in schizophrenia.